Pirbright’s new bird flu vaccine provides rapid protection, could reduce virus spread and is less costly to produce
Posted: 15 July, 2021
An improved poultry influenza vaccine has been developed by researchers from The Pirbright Institute. The potential vaccine triggers a rapid immune response which protects chickens against signs of disease and reduces the level of virus that they could pass on, a key element to halting the spread of bird flu through flocks. The vaccine would also be easier and less costly to produce than the traditional flu vaccines made in chicken eggs.
